Divi's Laboratories Limited (DIVISLAB) — share transfer
Divi's Laboratories submitted a SEBI-mandated certificate from its share transfer agent KFin Technologies for the quarter ended June 30, 2026, confirming dematerialization and rematerialization of securities on both NSE and BSE exchanges. The filing details acceptance/rejection status and registrar verification procedures.
About Divi's Laboratories Limited (DIVISLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Recent Announcements from Divi's Laboratories Limited
-
encumbrance — 6 July 2026
No summary available -
🟡 Board Meeting — 11 June 2026
Divi's Laboratories announced a ₹30 per share dividend for FY2025-26, payable after August 14, 2026, to shareholders on record as of July 24, 2026, su... -
🔴 Financial Results — 23 May 2026
Divi's Laboratories announced that the audio recording of its Q4 FY26 earnings conference call held on May 23, 2026, is now available on its website u... -
🔴 Financial Results — 31 March 2026
Divi's Laboratories announced closure of its trading window effective April 1, 2026, ahead of audited financial results for the quarter and year ended... -
🔴 Announcement — 21 March 2026
Divi's Laboratories received a Draft Assessment Order from the Income Tax Authority for FY2022-23 proposing **₹570.51 crores** in additions/disallowan...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when DIVISLAB files new disclosures
Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DIVISLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research